Anti-LRP1B/ LRP-1B/ LRP-DIT monoclonal antibody
Anti-LRP1B/ LRP-1B/ LRP-DIT antibody for FACS & in-vivo assay
Go to LRP1B/LRP1B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP0755-Ab-1/ GM-Tg-hg-MP0755-Ab-2 | Anti-Human LRP1B monoclonal antibody | Human |
GM-Tg-rg-MP0755-Ab-1/ GM-Tg-rg-MP0755-Ab-2 | Anti-Rat LRP1B monoclonal antibody | Rat |
GM-Tg-mg-MP0755-Ab-1/ GM-Tg-mg-MP0755-Ab-2 | Anti-Mouse LRP1B monoclonal antibody | Mouse |
GM-Tg-cynog-MP0755-Ab-1/ GM-Tg-cynog-MP0755-Ab-2 | Anti-Cynomolgus/ Rhesus macaque LRP1B monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP0755-Ab-1/ GM-Tg-felg-MP0755-Ab-2 | Anti-Feline LRP1B monoclonal antibody | Feline |
GM-Tg-cang-MP0755-Ab-1/ GM-Tg-cang-MP0755-Ab-2 | Anti-Canine LRP1B monoclonal antibody | Canine |
GM-Tg-bovg-MP0755-Ab-1/ GM-Tg-bovg-MP0755-Ab-2 | Anti-Bovine LRP1B monoclonal antibody | Bovine |
GM-Tg-equg-MP0755-Ab-1/ GM-Tg-equg-MP0755-Ab-2 | Anti-Equine LRP1B monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP0755-Ab-1/ GM-Tg-hg-MP0755-Ab-2; GM-Tg-rg-MP0755-Ab-1/ GM-Tg-rg-MP0755-Ab-2; GM-Tg-mg-MP0755-Ab-1/ GM-Tg-mg-MP0755-Ab-2; GM-Tg-cynog-MP0755-Ab-1/ GM-Tg-cynog-MP0755-Ab-2; GM-Tg-felg-MP0755-Ab-1/ GM-Tg-felg-MP0755-Ab-2; GM-Tg-cang-MP0755-Ab-1/ GM-Tg-cang-MP0755-Ab-2; GM-Tg-bovg-MP0755-Ab-1/ GM-Tg-bovg-MP0755-Ab-2; GM-Tg-equg-MP0755-Ab-1/ GM-Tg-equg-MP0755-Ab-2 |
Products Name | Anti-LRP1B monoclonal antibody |
Format | mab |
Target Name | LRP1B |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-LRP1B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species LRP1B/ LRP-1B/ LRP-DIT VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP0755 |
Target Name | LRP1B |
Gene ID | 53353,94217,311926,721791,476136,101082332,100336528,106781898 |
Gene Symbol and Synonyms | 9630004P12Rik,AABR07051892.1,LRP-1B,LRP-DIT,LRP1B,LRPDIT |
Uniprot Accession | Q9NZR2 |
Uniprot Entry Name | LRP1B_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000168702 |
Target Classification | N/A |
The target: LRP1B, gene name: LRP1B, also named as LRP-1B, LRP-DIT, LRPDIT. This gene encodes a member of the low density lipoprotein (LDL) receptor family. These receptors play a wide variety of roles in normal cell function and development due to their interactions with multiple ligands. Disruption of this gene has been reported in several types of cancer. [provided by RefSeq, Jun 2016].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.